LGND logo

LGND Operating expenses

annual operating expenses:

$133.04M+$22.06M(+19.87%)
December 31, 2024

Summary

  • As of today (May 24, 2025), LGND annual total operating expenses is $133.04 million, with the most recent change of +$22.06 million (+19.87%) on December 31, 2024.
  • During the last 3 years, LGND annual operating expenses has risen by +$57.52 million (+76.17%).
  • LGND annual operating expenses is now -5.23% below its all-time high of $140.38 million, reached on December 31, 2022.

Performance

LGND Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

quarterly operating expenses:

$77.14M+$38.85M(+101.48%)
March 31, 2025

Summary

  • As of today (May 24, 2025), LGND quarterly total operating expenses is $77.14 million, with the most recent change of +$38.85 million (+101.48%) on March 31, 2025.
  • Over the past year, LGND quarterly operating expenses has increased by +$52.03 million (+207.24%).
  • LGND quarterly operating expenses is now at all-time high.

Performance

LGND quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

LGND Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.9%+207.2%
3 y3 years+76.2%+159.9%
5 y5 years+16.0%+212.4%

LGND Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.2%+76.2%at high+207.2%
5 y5-year-5.2%+76.2%at high+703.1%
alltimeall time-5.2%+1300.4%at high+317.0%

LGND Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$77.14M(+101.5%)
Dec 2024
$133.04M(+19.9%)
$38.29M(-0.3%)
Sep 2024
-
$38.41M(+23.0%)
Jun 2024
-
$31.23M(+24.4%)
Mar 2024
-
$25.11M(-15.8%)
Dec 2023
$110.98M(-20.9%)
$29.82M(+4.9%)
Sep 2023
-
$28.43M(+6.5%)
Jun 2023
-
$26.68M(+2.4%)
Mar 2023
-
$26.06M(-46.7%)
Dec 2022
$140.38M(+85.9%)
$48.87M(+49.3%)
Sep 2022
-
$32.73M(+12.5%)
Jun 2022
-
$29.10M(-2.0%)
Mar 2022
-
$29.68M(-332.1%)
Dec 2021
$75.52M(-33.0%)
-$12.79M(-133.9%)
Sep 2021
-
$37.68M(+351.7%)
Jun 2021
-
$8.34M(-80.3%)
Mar 2021
-
$42.28M(+42.6%)
Dec 2020
$112.76M(-1.7%)
$29.64M(-6.6%)
Sep 2020
-
$31.75M(+19.0%)
Jun 2020
-
$26.68M(+8.0%)
Mar 2020
-
$24.69M(-29.9%)
Dec 2019
$114.66M(+40.9%)
$35.24M(+31.4%)
Sep 2019
-
$26.82M(+0.4%)
Jun 2019
-
$26.71M(+3.2%)
Mar 2019
-
$25.88M(+10.2%)
Dec 2018
$81.39M(+20.3%)
$23.49M(+12.7%)
Sep 2018
-
$20.84M(+11.2%)
Jun 2018
-
$18.73M(+2.2%)
Mar 2018
-
$18.33M(-10.1%)
Dec 2017
$67.66M(+13.7%)
$20.38M(+40.6%)
Sep 2017
-
$14.50M(+3.0%)
Jun 2017
-
$14.08M(-24.8%)
Mar 2017
-
$18.71M(+17.4%)
Dec 2016
$59.52M(+53.5%)
$15.93M(+5.1%)
Sep 2016
-
$15.15M(+2.2%)
Jun 2016
-
$14.83M(+9.1%)
Mar 2016
-
$13.60M(+34.9%)
Dec 2015
$38.78M(+11.8%)
$10.08M(+34.2%)
Sep 2015
-
$7.51M(-33.2%)
Jun 2015
-
$11.23M(+12.8%)
Mar 2015
-
$9.96M(+13.2%)
Dec 2014
$34.69M(+27.3%)
$8.80M(-9.9%)
Sep 2014
-
$9.76M(+23.1%)
Jun 2014
-
$7.93M(-3.4%)
Mar 2014
-
$8.20M(+20.7%)
Dec 2013
$27.26M(+2.6%)
$6.79M(-5.2%)
Sep 2013
-
$7.17M(+13.3%)
Jun 2013
-
$6.33M(-9.2%)
Mar 2013
-
$6.97M(+4.3%)
Dec 2012
$26.57M(+6.8%)
$6.68M(-4.0%)
Sep 2012
-
$6.95M(+3.7%)
Jun 2012
-
$6.71M(+7.6%)
Mar 2012
-
$6.23M(+5.3%)
Dec 2011
$24.87M(-28.7%)
$5.92M(-8.0%)
Sep 2011
-
$6.43M(-9.3%)
Jun 2011
-
$7.09M(+30.6%)
Mar 2011
-
$5.43M(-158.3%)
Dec 2010
$34.90M(-50.4%)
-$9.32M(-139.0%)
Sep 2010
-
$23.90M(+141.6%)
Jun 2010
-
$9.89M(-5.0%)
Mar 2010
-
$10.41M(-69.9%)
Dec 2009
$70.32M
$34.57M(+385.1%)
DateAnnualQuarterly
Sep 2009
-
$7.13M(-39.7%)
Jun 2009
-
$11.81M(-31.7%)
Mar 2009
-
$17.28M(+9.8%)
Dec 2008
$54.55M(-27.3%)
$15.74M(+35.7%)
Sep 2008
-
$11.60M(+11.2%)
Jun 2008
-
$10.44M(-39.5%)
Mar 2008
-
$17.26M(+9.4%)
Dec 2007
$75.03M(-8.6%)
$15.78M(+11.1%)
Sep 2007
-
$14.20M(-10.0%)
Jun 2007
-
$15.78M(-46.1%)
Mar 2007
-
$29.28M(+25.9%)
Dec 2006
$82.06M(+52.4%)
$23.26M(+3.6%)
Sep 2006
-
$22.45M(+17.4%)
Jun 2006
-
$19.12M(+11.0%)
Mar 2006
-
$17.23M(-148.5%)
Dec 2005
$53.84M(-50.7%)
-$35.55M(-217.8%)
Sep 2005
-
$30.17M(-27.5%)
Jun 2005
-
$41.64M(-0.1%)
Mar 2005
-
$41.69M(-398.5%)
Dec 2004
$109.23M(-15.0%)
-$13.97M(-137.0%)
Sep 2004
-
$37.72M(-9.5%)
Jun 2004
-
$41.68M(-39.6%)
Mar 2004
-
$68.95M(+80.7%)
Dec 2003
$128.58M(+27.5%)
$38.17M(+23.5%)
Sep 2003
-
$30.91M(+1.6%)
Jun 2003
-
$30.43M(+4.7%)
Mar 2003
-
$29.07M(+4.8%)
Dec 2002
$100.89M(+18.0%)
$27.75M(+5.1%)
Sep 2002
-
$26.41M(+10.2%)
Jun 2002
-
$23.96M(+5.2%)
Mar 2002
-
$22.77M(+9.5%)
Dec 2001
$85.53M(+0.2%)
$20.80M(+3.6%)
Sep 2001
-
$20.09M(-12.7%)
Jun 2001
-
$23.01M(-2.1%)
Mar 2001
-
$23.50M(+12.0%)
Dec 2000
$85.40M(-6.9%)
$20.98M(-3.7%)
Sep 2000
-
$21.79M(-17.4%)
Jun 2000
-
$26.36M(+23.3%)
Mar 2000
-
$21.39M(+32.0%)
Dec 1999
$91.70M(-0.1%)
$16.20M(-37.2%)
Sep 1999
-
$25.80M(-1.5%)
Jun 1999
-
$26.20M(+11.5%)
Mar 1999
-
$23.50M(-13.9%)
Dec 1998
$91.80M(-0.5%)
$27.30M(+20.8%)
Sep 1998
-
$22.60M(+0.9%)
Jun 1998
-
$22.40M(+14.9%)
Mar 1998
-
$19.50M(-26.1%)
Dec 1997
$92.30M(+16.7%)
$26.40M(+14.8%)
Sep 1997
-
$23.00M(+6.5%)
Jun 1997
-
$21.60M(+1.9%)
Mar 1997
-
$21.20M(-6.6%)
Dec 1996
$79.10M(+49.0%)
$22.70M(+4.6%)
Sep 1996
-
$21.70M(+16.7%)
Jun 1996
-
$18.60M(+16.3%)
Mar 1996
-
$16.00M(-3.0%)
Dec 1995
$53.10M(+458.9%)
$16.50M(+8.6%)
Sep 1995
-
$15.20M(+61.7%)
Mar 1995
-
$9.40M(+176.5%)
Dec 1994
$9.50M
$3.40M(+61.9%)
Sep 1994
-
$2.10M(+5.0%)
Jun 1994
-
$2.00M(0.0%)
Mar 1994
-
$2.00M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual total operating expenses?
  • What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual total operating expenses?

The current annual operating expenses of LGND is $133.04M

What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual total operating expenses is $140.38M

What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?

Over the past year, LGND annual total operating expenses has changed by +$22.06M (+19.87%)

What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?

The current quarterly operating expenses of LGND is $77.14M

What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly total operating expenses is $77.14M

What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?

Over the past year, LGND quarterly total operating expenses has changed by +$52.03M (+207.24%)
On this page